CLINICAL RELEVANCE: DRUG–DRUG INTERACTION,PHARMACOKINETICS,PHARMACODYNAMICS, AND TOXICITY - Drug Transporters: Molecular Characterization and Role in Drug Disposition - page 833

260. Conseil G, Baubichon-Cortay H, Dayan G, Jault JM, Barron D, Di Pietro A. 1998.
Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and
steroid-binding sites on mouse P-glycoprotein. Proc Natl Acad Sci U S A 95: 9831-
9836.
261. Ho PC, Saville DJ, Wanwimolruk S. 2001. Inhibition of human CYP3A4 activity by
grapefruit flavonoids, furanocoumarins and related compounds. J Pharm Pharm Sci 4:
217-227.
262. Yoshikawa M, Ikegami Y, Sano K, Yoshida H, Mitomo H, Sawada S, Ishikawa T. 2004.
Transport of SN-38 by the wild-type of human ABC transporter ABCG2 and its inhibition
by quercetin, a natural flavonoid. J Exp Ther Oncol 4: 25-35.
263. Zhang S, Yang X, Morris ME. 2004. Combined effects of multiple flavonoids on breast
cancer resistance protein (ABCG2)-mediated transport. Pharm Res 21: 1263-1273.
264. Zhang S, Yang X, Morris ME. 2004. Flavonoids are inhibitors of breast cancer resistance
protein (ABCG2)-mediated transport. Mol Pharmacol 65: 1208-1216.
265. Zhang S, Wang X, Sagawa K, Morris ME. 2005. Flavonoids chrysin and benzoflavone,
potent breast cancer resistance protein inhibitors, have no significant effect on topotecan
pharmacokinetics in rats or mdr1a/1b ( − / − ) mice. Drug Metab Dispos 33: 34134-3418.
266. Pavek P, Merino G, Wagenaar E, Bolscher E, Novotna M, Jonker JW, Schinkel AH. 2005.
Human breast cancer resistance protein: interactions with steroid drugs, hormones, the
dietary carcinogen 2-amino-1-methyl-6-phenylimidazo(4,5- b )pyridine, and transport of
cimetidine. J Pharmacol Exp Ther 312: 144-152.
267. Sugimoto Y, Tsukahara S, Imai Y, Sugimoto Y, Ueda K, Tsuruo T. 2003. Reversal of
breast cancer resistance protein-mediated drug resistance by estrogen antagonists and
agonists. Mol Cancer Ther 2: 105-112.
268. Guo Y, Kotova E, Chen ZS, Lee K, Hopper-Borge E, Belinsky MG, Kruh GD. 2003.
MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump
and a resistance factor for fluoropyrimidines 2 ,3 -dideoxycytidine and 9 -(2 -phosp-
honylmethoxyethyl)adenine. J Biol Chem 278: 29509-29514.
269. Wijnholds J, Mol CA, van Deemter L, de Haas M, Scheffer GL, Baas F, Beijnen JH,
Scheper RJ, Hatse S, De Clercq E, Balzarini J, Borst P. 2000 Multidrug-resistance protein 5
is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl
Acad SciUSA97:7476-7481.
270. Wijnholds J. 2002. Drug resistance caused by multidrug resistance-associated proteins.
Novartis Found Symp 243: 69-79.
271. Gornet JM, Lokiec F, Dclos-Vallee JC, Azoulay D, Goldwasser F. 2001. Severe CPT-11-
induced diarrhea in presence of FK-506 following liver transplantation for hepatocelluler
carcinoma. Anticancer Res 21: 4203-4206.
272. Capece BP, Castells G, Perez F, Arboix M, Cristofol C. 2000. Pharmacokinetic behaviour
of albendazole sulphoxide enantiomers in male and female sheep. Vet Res Commun 24:
339-348.
273. Merino G, Jonker JW, Wagenaar E, Pulido MM, Molina AJ, Alvarez AI, Schinkel AH.
2005. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein
(BCRP/ABCG2). Drug Metab Dispos 33: 614-618.
274. Morton MR, Cooper JW. 1989. Erythromycin-induced digoxin toxicity. DICP 23: 668-
670. Abstract only.